Literature DB >> 21852339

Dietary factors and lung function in the general population: wine and resveratrol intake.

M Siedlinski1, J M A Boer, H A Smit, D S Postma, H M Boezen.   

Abstract

Wine intake is associated with a better lung function in the general population, yet the source of this effect is unknown. Resveratrol, a polyphenol in wine, has anti-inflammatory properties in the lung, its effects being partially mediated via induction of Sirtuin (SIRT)1 activity. We assessed the impact of wine and resveratrol intake, and SIRT1 single-nucleotide polymorphisms (SNPs) on lung function in the general population. Effects of red and white wine and resveratrol intake on forced expiratory volume in 1 s (FEV(1)), forced vital capacity (FVC) and FEV(1)/FVC were analysed in the population-based Doetinchem cohort (n=3,224). Associations of four tagging SIRT1 SNPs with lung function were analysed in the Doetinchem (n=1,152) and Vlagtwedde-Vlaardingen (n=1,390) cohorts. Resveratrol intake was associated with higher FVC levels, and white wine intake with higher FEV(1) levels and lower risk of airway obstruction. SIRT1 SNPs were not significantly associated with level or course of lung function, either directly or indirectly via wine or resveratrol intake. This study shows a positive association of resveratrol intake with lung function in the general population, confirms the previously reported positive association of white wine intake with higher levels of FEV(1), and additionally shows an association with a higher FEV(1)/FVC ratio. These effects probably do not run via SNPs in SIRT1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852339     DOI: 10.1183/09031936.00184110

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.

Authors:  Julia K Bird; Daniel Raederstorff; Peter Weber; Robert E Steinert
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

2.  The Association Between Dietary Intake and Phenotypical Characteristics of COPD in the ECLIPSE Cohort.

Authors:  Corrine Hanson; Harlan Sayles; Erica E P A Rutten; E F M Wouters; William MacNee; Peter Calverley; Jane L Meza; Stephen Rennard
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

3.  Nutrition as a modifiable factor in the onset and progression of pulmonary function impairment in COPD: a systematic review.

Authors:  Lieke E J van Iersel; Rosanne J H C G Beijers; Harry R Gosker; Annemie M W J Schols
Journal:  Nutr Rev       Date:  2022-05-09       Impact factor: 6.846

4.  Common SIRT1 variants modify the effect of abdominal adipose tissue on aging-related lung function decline.

Authors:  Ivan Curjuric; Medea Imboden; Pierre-Olivier Bridevaux; Margaret W Gerbase; Margot Haun; Dirk Keidel; Ashish Kumar; Marco Pons; Thierry Rochat; Tamara Schikowski; Christian Schindler; Arnold von Eckardstein; Florian Kronenberg; Nicole M Probst-Hensch
Journal:  Age (Dordr)       Date:  2016-04-28

Review 5.  Oxidative stress and free radicals in COPD--implications and relevance for treatment.

Authors:  Wolfgang Domej; Karl Oettl; Wilfried Renner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-17

Review 6.  Food Pyramid for Subjects with Chronic Obstructive Pulmonary Diseases.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Gabriella Peroni; Vittoria Infantino; Clara Gasparri; Giancarlo Iannello; Simone Perna; Tariq AbdulKarim Alalwan; Salwa Al-Thawadi; Angelo Guido Corsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-19

Review 7.  Potential Micronutrients and Phytochemicals against the Pathogenesis of Chronic Obstructive Pulmonary Disease and Lung Cancer.

Authors:  Ting Zhai; Shizhen Li; Wei Hu; Duo Li; Shuguang Leng
Journal:  Nutrients       Date:  2018-06-25       Impact factor: 5.717

8.  SIRT1 polymorphism, long-term survival and glucose tolerance in the general population.

Authors:  Sylwia M Figarska; Judith M Vonk; H Marike Boezen
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.